Expression of growth factors and their receptors in neuroendocrine gut and pancreatic tumors, and prognostic factors for survival.
Oberg
K
K
Department of Internal Medicine, University Hospital, Uppsala, Sweden.
D014408:Biomarkers, Tumor; D002276:Carcinoid Tumor / Q000453:epidemiology / Q000235:genetics / Q000401:mortality / Q000473:pathology*; D005770:Gastrointestinal Neoplasms / Q000453:epidemiology / Q000235:genetics / Q000401:mortality / Q000473:pathology*; D006133:Growth Substances / Q000032:analysis / Q000096:biosynthesis*; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism*; D018358:Neuroendocrine Tumors / Q000453:epidemiology / Q000235:genetics / Q000401:mortality / Q000473:pathology*; D009490:Neurosecretory Systems / Q000378:metabolism*; D010190:Pancreatic Neoplasms / Q000453:epidemiology / Q000235:genetics / Q000401:mortality / Q000473:pathology*; D011237:Predictive Value of Tests; D011379:Prognosis; D017978:Receptors, Growth Factor / Q000032:analysis / Q000096:biosynthesis*; D015996:Survival Rate
D014408:Biomarkers, Tumor; D006133:Growth Substances; D017978:Receptors, Growth Factor